Background illustration for clinical trials search

Paid Clinical Trials Torrance

Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

for
Healthy Participants, Dyslipidemia
Location: Glendale CA, San Antonio TX, Inverness FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06980428

Phase 1, Recruiting

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

for
Multiple Myeloma
Location: Duarte CA, Denver CO, Houston TX, Iowa City IA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07073547

Phase 1, Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Los Angeles CA, Orange CA, La Jolla CA, Palo Alto CA,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase 3, Recruiting

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Los Angeles CA, Chicago IL, Tampa FL, New Hyde Park NY
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06121180

Phase 2, Recruiting

PH Sensitive MRI Based Resections of Glioblastoma

for
Glioblastoma
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18+

Code: NCT06176066

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Social Facilitation of Emotion Regulation in Adolescence

for
Emotion Regulation
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 13 - 25

Code: NCT06458920

Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Los Angeles CA, Englewood CO, Fort Worth TX,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for
Unresectable Melanoma, Metastatic Melanoma,
Location: Los Angeles CA, Westwood KS, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase 1, Phase 2, Recruiting

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

for
Acute Ischemic Stroke, Cerebral Stroke
Location: Oxnard CA, Carmichael CA, Tucson AZ, Houston TX,
Sponsor: Pharmazz, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05691244

Phase 3, Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Los Angeles CA, Portland OR, Houston TX,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase 1, Phase 2, Recruiting

Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

for
Stage III Melanoma, Stage IV Melanoma
Location: Los Angeles CA, Denver CO
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT03385486

Phase 1, Recruiting

Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope

for
Pulmnary Hypertension
Location: Los Angeles CA
Sponsor: Eko Devices, Inc.

Sex: All

Age: 18+

Code: NCT07136623

Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Los Angeles CA, San Francisco CA, Irving TX, Dallas TX,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase 1, Phase 2, Recruiting

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

for
Melanoma Stage IV, Solid Tumor
Location: Los Angeles CA, Fullerton CA, Bakersfield CA,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06425926

Phase 1, Phase 2, Recruiting

SNV4818 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Los Angeles CA, Houston TX, Nashville TN, Toronto,
Sponsor: Pikavation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06736704

Phase 1, Phase 2, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: Los Angeles CA, Stanford CA, Houston TX, Louisville KY,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase 1, Phase 2, Recruiting

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Fullerton CA, Newport Beach CA, La Jolla CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06997029

Phase 1, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Los Angeles CA, La Jolla CA, Palo Alto CA,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

for
Neoplasms, Tenosynovial Giant Cell Tumor
Location: Beverly Hills CA
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT04192344

Phase 1, Recruiting